STANFORD, CALIF. — Stanford University researchers published a study in the journal Nature on September 16, 2026, describing mice that received transplants of lab-grown human brain organoids. The team, led by Sergiu Pașca, demonstrated that the human tissue integrated into the rodent nervous systems and restored some cognitive functions in animals engineered to lack most of their cerebral cortex. "For the past two decades, there's been a quest to try to build models of the human brain outside of the human body," Sergiu Pașca said. "This is not going to replace all the models we had before, but it's going to provide us access to other aspects of human brain function that would be very difficult to study otherwise," Sergiu Pașca said.

Researchers genetically engineered mice to be missing most of their cerebral cortex and hippocampus, regions that account for about half of the mouse brain's total volume. The resulting animals develop only 2% of their cerebral cortex. Within a few days of birth, scientists transplanted lab-grown human brain organoids into the vacant space in the mice brains. The transplantation of human brain tissue was successful in 25 of 29 attempts.

The human brain tissue expanded nearly fivefold in volume over three months, filling more than 90 percent of the mouse cortex. Researchers removed approximately 14 million mouse neurons and added around 4 million lab-grown human cortical neurons during the procedure. "We gently place them, through a very quick, simple procedure, right into that vacant space in the nervous system of the mouse," Pașca said. "Within a few days, the cell starts to divide and expand."

Human brain cells develop at least 20 times slower than mouse brain cells, a difference that persisted despite the faster-maturing host environment. "Even when they're put in an animal, in a mouse or in a rat, they will still develop about 20 times slower than the mouse or the rat," Pașca said. The human neurons in the grafts did not organize into the characteristic layered structure of a typical human cortex.

"The cortex is usually beautifully organized into layers," he said. "But here, when we put the cells in, they don't know where up and down really is."

Mice lacking most of their cerebral cortex displayed good locomotion but performed poorly on memory tasks. Mice with human brain cell grafts performed better on memory tasks and social interaction tests than mice with depleted brains. The grafted mice's performance on fine motor control and memory tests fell between that of mice with intact brains and mice lacking a cortex.

"Many of the deficits that were present in the [depleted] mice are now not present in this animal," Pașca said. "So it seems that the human cortical cells are perhaps contributing to restoring some of these lost functions."

Human brain tissue in the mice developed into a range of cell types, including pyramidal projection neurons that extended into the spinal cord. Researchers found evidence of specialized neurons involved in social cognition, which are typically found only in large-brain mammals, within the grafts. In proof-of-concept tests, researchers exposed the xenocortical mice to low oxygen levels for five hours, causing severe, selective damage to human neurons that mimics the cellular breakdown associated with cerebral palsy in human infants. Mice with human brain cells exhibited walking problems after oxygen deprivation, whereas unaltered mice are resilient to low-oxygen conditions.

The study suggests xenocortication could be useful for obtaining circuit- and behavior-level readouts using human neurons to model diseases such as epilepsy, autism, and cerebral palsy. "Our goal has been to make aspects of human brain development and function accessible for investigation, so we can develop therapeutics," Pașca said. "The human brain, which is likely the source for these conditions, is not accessible." He noted that unlike other organs, the human brain cannot be probed or tested in a living individual.

The researchers halted the experiments when the human brain cells reached approximately six months of age. The six-month endpoint was chosen to occur before the human cells could form connections associated with consciousness. Nita Farahany, a professor of law and philosophy at Duke Law who served as an unpaid member of an external ethics board that guided the research, addressed the timeline. "They're trying to stop the study before the markers of consciousness, or the fact of consciousness, might emerge," Farahany said.

Hongkui Zeng, executive vice president and director of brain science at the Allen Institute in Seattle, Washington, was not affiliated with the study but commented on the findings. "It's really a powerful technology to study human neurons and how human brain circuits can form in a more natural environment than a petri dish," Zeng said. He noted the adaptability of the host animals.

"Surprisingly, the animal can adapt," Zeng said. "It's incredible to see that." He added that "going forward, there will be some considerations, if not concerns."

Why It Matters

This research addresses a long-standing limitation in neuroscience by creating a model where human neural tissue can develop within a living organism. For two decades, scientists have sought to build models of the human brain outside the human body, but existing methods often lack the complex environment required for proper circuit formation. The study demonstrates that human cells can integrate across a species barrier and respond to injury in ways that mimic human disease, offering a new avenue for testing therapeutics for conditions like cerebral palsy.

The integration of human tissue into animal hosts raises ethical questions regarding cognitive capacity and consciousness. The research team established specific boundaries, such as halting experiments before potential consciousness markers could emerge and avoiding the use of primate hosts. These measures aim to balance the scientific need for accessible human brain models with ethical obligations, providing a framework for future studies that may challenge traditional assumptions about neural development and interspecies chimeras.

What's New

Additional reporting provides further detail on the motivations and ethical frameworks surrounding the study. Sergiu Pașca stated that the primary objective is therapeutic development, noting that the human brain is not accessible for direct probing in living individuals. He emphasized that the goal is to make aspects of human brain development available for investigation to help develop treatments.

Ethical perspectives from outside experts describe the complexity of the work. Insoo Hyun, a bioethicist at the National University of Singapore Yong Loo Lin School of Medicine, noted that from a secular ethical point of view, the issue boils down to cognitive capacity. H. Isaac Chen, a neurosurgeon at the University of Pennsylvania who was not involved in the research, observed that the model offers significant potential for examining larger areas of human neural tissue from a cellular and molecular perspective. Carsten Charlesworth, a scientist at Stanford University who was not involved in the research, remarked on the extent to which the human neural tissue grew and connected with the mouse nervous system across a species barrier.

How Sources Differ

Descriptions of the genetic engineering process vary in specificity. Nature journal study data states that the genetically engineered mice develop only 2% of their cerebral cortex. In contrast, the Nature journal study methods section describes the process more broadly, stating that researchers genetically engineered mice to be missing most of their cerebral cortex and hippocampus.